Protalix BioTherapeutics (PLX) Interest Coverage Ratio Growth (3y) (2016 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 79.36% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 29.25% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -16.86% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -1.78% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 40.09% |
| 10 | Protalix BioTherapeutics | 164.49 Mn | 153.70 Mn | 29.62 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | -511.19% |
| Dec 31, 2024 | 210.65% |
| Sep 30, 2024 | 178.60% |
| Jun 30, 2024 | -15.46% |
| Mar 31, 2024 | -93.50% |
| Dec 31, 2023 | -103.62% |
| Sep 30, 2023 | -46.35% |
| Jun 30, 2023 | 149.91% |
| Mar 31, 2023 | -66.39% |
| Dec 31, 2022 | 122.06% |
| Sep 30, 2022 | -86.56% |
| Jun 30, 2022 | -42.54% |
| Mar 31, 2022 | -1.63% |
| Dec 31, 2021 | -47.13% |
| Sep 30, 2021 | 27.66% |
| Jun 30, 2021 | -3.42% |
| Mar 31, 2021 | 9.52% |
| Dec 31, 2020 | 28.21% |
| Sep 30, 2020 | 14.72% |
| Jun 30, 2020 | 31.31% |
| Mar 31, 2020 | 35.30% |
| Dec 31, 2019 | 29.63% |
| Sep 30, 2019 | 53.11% |
| Jun 30, 2019 | 34.75% |
| Mar 31, 2019 | 30.80% |
| Dec 31, 2018 | 38.00% |
| Sep 30, 2018 | 24.79% |
| Jun 30, 2018 | 24.38% |
| Mar 31, 2018 | 20.70% |
| Mar 31, 2017 | 24.44% |
| Mar 31, 2016 | 69.82% |